WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 6.1% of their position (12K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $4.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/20/2025ACC: 0001213900-25-113104
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+12K
Net shares
Net buyer
$4.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
12K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.50K
Price / share
$0.40
Trade value
$3.02K
% of position
3.8%
11/18/2025
197.93K→205.43K
Common Stock
Direct
Shares
+4.50K
Price / share
$0.41
Trade value
$1.82K
% of position
2.2%
11/19/2025
205.43K→209.93K
Total
Net shares
+12K
Net value
$4.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2025 | P · Purchase | +7.50K | $0.40 | $3.02K | 3.8% | 197.93K | 205.43K |
| Common Stock Direct | 11/19/2025 | P · Purchase | +4.50K | $0.41 | $1.82K | 2.2% | 205.43K | 209.93K |
| Total | +12K | $4.85K | ||||||
Derivative Transactions0
No derivative transactions reported